Causes and predictors of readmission after transcatheter aortic valve implantation

Herz - Tập 46 - Trang 1-8 - 2019
Yi-ming Li1, Fu-yang Mei2, Yi-jun Yao3, Jia-yu Tsauo1, Yong Peng1, Mao Chen1
1Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China
2Zhejiang Provincial People’s Hospital, Hangzhou, China
3West China School of Medicine, Sichuan University, Chengdu, China

Tóm tắt

Since readmission rate is an important clinical index to determine the quality of inpatient care and hospital performance, the aim of this study was to explain the causes and predictors of readmission following transcatheter aortic valve implantation (TAVI) at short-term and mid-term follow-up. A systematic review and meta-analysis of all published articles from Embase, Pubmed/MEDLINE, and Ovid was carried out. In all, 10 studies including 52,702 patients were identified. The pooled estimate for the overall event rate was 0.15, and cardiovascular causes were the main reason for 30-day readmission (0.42, 95% confidence interval [CI]: 0.39–0.45). In addition, the pooled incidence of 1‑year readmission was 0.31, and cardiovascular events were still the main cause (0.41, 95% CI: 0.33–0.48). Patients with major and life-threatening bleeding, new permanent pacemaker implantation, and clinical heart failure were associated with a high risk for early readmission after TAVI. Moreover, an advanced (≥3) New York Heart Association classification, acute kidney injury, paravalvular leak, mitral regurgitation (≥ moderate), and major bleeding predicted unfavorable outcome to 1‑year readmission. Female gender and transfemoral TAVI was associated with a lower risk for unplanned rehospitalization. This meta-analysis found cardiovascular factors to be the main causes for both 30-day and 1‑year rehospitalization. Heart failure represented the most common cardiovascular event at both short-term and mid-term follow-up. Several baseline characteristics and procedure-related factors were deemed unfavorable predictors of readmission. Importantly, transfemoral access and female gender were associated with a lower risk of readmission.

Tài liệu tham khảo

Cahill TJ, Chen M, Hayashida K et al (2018) Transcatheter aortic valve implantation: current status and future perspectives. Eur Heart J 39(28):2625–2634. https://doi.org/10.1093/eurheartj/ehy244

Smith CR, Leon MB, Mack MJ et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198. https://doi.org/10.1056/NEJMoa1103510

Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374(17):1609–1620. https://doi.org/10.1056/NEJMoa1514616

Reardon MJ, Van Mieghem NM, Popma JJ et al (2017) Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 376(14):1321–1331. https://doi.org/10.1056/NEJMoa1700456

Thourani VH, Kodali S, Makkar RR et al (2016) Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 387(10034):2218–2225. https://doi.org/10.1016/s0140-6736(16)30073-3

Indraratna P, Ang SC, Gada H et al (2014) Systematic review of the cost-effectiveness of transcatheter aortic valve implantation. J Thorac Cardiovasc Surg 148(2):509–514. https://doi.org/10.1016/j.jtcvs.2013.10.023

Van Brabandt H, Neyt M, Hulstaert F (2012) Transcatheter aortic valve implantation (TAVI): risky and costly. Bmj 345:e4710. https://doi.org/10.1136/bmj.e4710

Epstein AM, Jha AK, Orav EJ (2011) The relationship between hospital admission rates and rehospitalizations. N Engl J Med 365(24):2287–2295. https://doi.org/10.1056/NEJMsa1101942

Jencks SF, Williams MV, Coleman EA (2009) Rehospitalizations among patients in the medicare fee-for-service program. N Engl J Med 360(14):1418–1428. https://doi.org/10.1056/NEJMsa0803563

Wells GA, Shea BJ, O’Connell D et al (2014) The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Appl Eng Agric 18(6):727–734

Barendregt JJ, Doi SA, Lee YY et al (2013) Meta-analysis of prevalence. J Epidemiol Community Health 67(11):974–978. https://doi.org/10.1136/jech-2013-203104

Freeman MF, Tukey JW (1950) Transformations related to the angular and the square root. Ann Math Stat 21(4):607–611

Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. https://doi.org/10.1136/bmj.b2535

Czarnecki A, Austin P, Fremes S et al (2017) Predictors of hospital readmission after trans-catheter aortic valve implantation. Can J Cardiol 33(10):S10–S11. https://doi.org/10.1016/j.cjca

Czarnecki A, Austin PC, Fremes SE et al (2019) Association between transitional care factors and hospital readmission after transcatheter aortic valve replacement: a retrospective observational cohort study. BMC Cardiovasc Disord 19(1):23. https://doi.org/10.1186/s12872-019-1003-9

Dodson JA, Williams MR, Cohen DJ et al (2017) Hospital practice of direct-home discharge and 30-day readmission after transcatheter aortic valve replacement in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy (STS/ACC TVT) Registry. J Am Heart Assoc. https://doi.org/10.1161/jaha.117.006127

Durand E, Doutriaux M, Dupré M et al (2017) Incidence, predictors and impact of readmission for heart failure after transcatheter aortic valve implantation. Arch Cardiovasc Dis 9(1):59. https://doi.org/10.1016/S1878-6480(17)30190-8 (supplement)

Forcillo J, Condado JF, Binongo JN et al (2017) Readmission rates after transcatheter aortic valve replacement in high- and extreme-risk patients with severe aortic stenosis. J Thorac Cardiovasc Surg 154(2):445–452. https://doi.org/10.1016/j.jtcvs.2017.03.144

Franzone A, Pilgrim T, Arnold N et al (2017) Rates and predictors of hospital readmission after transcatheter aortic valve implantation. Eur Heart J 38(28):2211–2217. https://doi.org/10.1093/eurheartj/ehx182

Hannan EL, Samadashvili Z, Jordan D et al (2015) Thirty-day readmissions after transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis in New York State. Circ Cardiovasc Interv 8(8):e2744. https://doi.org/10.1161/CIRCINTERVENTIONS.115.002744

Kolte D, Khera S, Sardar MR et al (2017) Thirty-day readmissions after transcatheter aortic valve replacement in the United States: insights from the nationwide readmissions database. Circ Cardiovasc Interv. https://doi.org/10.1161/CIRCINTERVENTIONS.116.004472

Nombela-Franco L, Trigo MD, Morrison-Polo G et al (2015) Incidence, causes, and predictors of early (≤30 days) and late unplanned hospital readmissions after transcatheter aortic valve replacement. JACC Cardiovasc Interv 8(13):1748–1757. https://doi.org/10.1016/j.jcin.2015.07.022

Arai T, Yashima F, Yanagisawa R et al (2018) Hospital readmission following transcatheter aortic valve implantation in the real world. Int J Cardiol 269:56–60. https://doi.org/10.1016/j.ijcard.2018.07.073

Khera S, Kolte D, Gupta T et al (2017) Association between hospital volume and 30-day readmissions following transcatheter aortic valve replacement. JAMA Cardiol 2(7):732–741. https://doi.org/10.1001/jamacardio.2017.1630

Holmes DR Jr, Brennan J, Rumsfeld JS et al (2015) Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA 313(10):1019–1028. https://doi.org/10.1001/jama.2015.1474

Lindman BR, Stewart WJ, Pibarot P et al (2014) Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations. JACC Cardiovasc Interv 7(6):662–673. https://doi.org/10.1016/j.jcin.2014.02.011

Gotzmann M, Rahlmann P, Hehnen T et al (2012) Heart failure in severe aortic valve stenosis: prognostic impact of left ventricular ejection fraction and mean gradient on outcome after transcatheter aortic valve implantation. Eur J Heart Fail 14(10):1155–1162. https://doi.org/10.1093/eurjhf/hfs108

Herrmann S, Stork S, Niemann M et al (2011) Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome. J Am Coll Cardiol 58(4):402–412. https://doi.org/10.1016/j.jacc.2011.02.059

Xiong TY, Liao YB, Zhao ZG et al (2015) Causes of death following transcatheter aortic valve replacement: a systematic review and meta-analysis. J Am Heart Assoc 4(9):e2096. https://doi.org/10.1161/JAHA.115.002096

Fadahunsi OO, Olowoyeye A, Ukaigwe A et al (2016) Incidence, Predictors, and Outcomes of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Analysis From the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry. JACC Cardiovasc Interv 9(21):2189–2199. https://doi.org/10.1016/j.jcin.2016.07.026

Nazif TM, Dizon José M, Hahn RT et al (2015) Predictors and clinical outcomes of permanent pacemaker implantation after Transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER valves) Trial and Registry. JACC Cardiovasc Interv 8(1):60–69. https://doi.org/10.1016/j.jcin.2014.07.022 (Part A)

Amat-Santos IJ, Messika-Zeitoun D, Eltchaninoff H et al (2015) Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry. Circulation 131(18):1566–1574. https://doi.org/10.1161/CIRCULATIONAHA.114.014089

Tsai TC, Joynt KE, Orav EJ et al (2013) Variation in surgical-readmission rates and quality of hospital care. N Engl J Med 369(12):1134

Biancari F, Rosato S, D’Errigo P et al (2016) Immediate and intermediate outcome after transapical versus transfemoral transcatheter aortic valve replacement. Am J Cardiol 117(2):245–251. https://doi.org/10.1016/j.amjcard.2015.10.036

Panchal HB, Ladia V, Amin P et al (2014) A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis. Am J Cardiol 114(12):1882–1890. https://doi.org/10.1016/j.amjcard.2014.09.029

Kodali S, Thourani VH, White J et al (2016) Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J 37(28):2252–2262. https://doi.org/10.1093/eurheartj/ehw112

Manoharan G, Walton AS, Brecker SJ et al (2015) Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system. JACC Cardiovasc Interv 8(10):1359–1367. https://doi.org/10.1016/j.jcin.2015.05.015

Konigstein M, Ben-Assa E, Banai S et al (2015) Periprocedural bleeding, acute kidney injury, and long-term mortality after transcatheter aortic valve implantation. Can J Cardiol 31(1):56–62. https://doi.org/10.1016/j.cjca.2014.11.006

Généreux P, Cohen DJ, Williams MR et al (2014) Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 63(11):1100–1109. https://doi.org/10.1016/j.jacc.2013.10.058

Nuis RJ, Rodes-Cabau J, Sinning JM et al (2012) Blood transfusion and the risk of acute kidney injury after transcatheter aortic valve implantation. Circ Cardiovasc Interv 5(5):680–688. https://doi.org/10.1161/CIRCINTERVENTIONS.112.971291

Haldenwang P, Trampisch M, Schlomicher M et al (2014) Risk factors for acute kidney injury following TA-TAVI or minimally invasive aortic valve replacement: which procedure is less kidney damaging in elderly patients? Thorac cardiovasc Surg 62(6):482–488. https://doi.org/10.1055/s-0034-1376201

Liao YB, Deng XX, Meng Y et al (2017) Predictors and outcome of acute kidney injury after transcatheter aortic valve implantation: a systematic review and meta-analysis. EuroIntervention 12(17):2067–2074. https://doi.org/10.4244/EIJ-D-15-00254

Takagi H, Umemoto T et al (2016) Impact of paravalvular aortic regurgitation after transcatheter aortic valve implantation on survival. Int J Cardiol 221:46–51. https://doi.org/10.1016/j.ijcard.2016.07.006

Pibarot P, Hahn RT, Weissman NJ et al (2017) Association of paravalvular regurgitation with 1‑year outcomes after transcatheter aortic valve replacement with the SAPIEN 3 Valve. JAMA Cardiol 2(11):1208–1216. https://doi.org/10.1001/jamacardio.2017.3425

Abdelghani M, Mankerious N, Allali A et al (2018) Bioprosthetic valve performance after transcatheter aortic valve replacement with self-expanding versus balloon-expandable valves in large versus small aortic valve annuli: insights from the CHOICE Trial and the CHOICE-Extend Registry. JACC Cardiovasc Interv 11(24):2507–2518. https://doi.org/10.1016/j.jcin.2018.07.050

Schulz E, Jabs A, Gori T et al (2016) Transcatheter aortic valve implantation with the new-generation Evolut R: comparison with CoreValve(R) in a single center cohort. Int J Cardiol Heart Vasc 12:52–56. https://doi.org/10.1016/j.ijcha.2016.06.002

Nombela-Franco L, Ribeiro HB, Urena M et al (2014) Significant mitral regurgitation left untreated at the time of aortic valve replacement: a comprehensive review of a frequent entity in the transcatheter aortic valve replacement era. J Am Coll Cardiol 63(24):2643–2658. https://doi.org/10.1016/j.jacc.2014.02.573

Toggweiler S, Boone RH, Rodes-Cabau J et al (2012) Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation. J Am Coll Cardiol 59(23):2068–2074. https://doi.org/10.1016/j.jacc.2012.02.020

O’Sullivan CJ, Wenaweser P, Ceylan O et al (2015) Effect of pulmonary hypertension hemodynamic presentation on clinical outcomes in patients with severe symptomatic aortic valve stenosis undergoing transcatheter aortic valve implantation: insights from the new proposed pulmonary hypertension classification. Circ Cardiovasc Interv 8(7):e2358. https://doi.org/10.1161/CIRCINTERVENTIONS.114.002358

Barbanti M, Dvir D, Tan J, Webb JG (2013) Aortic stenosis and mitral regurgitation: implications for transcatheter valve treatment. EuroIntervention 9(Suppl):S69–S71. https://doi.org/10.4244/EIJV9SSA13

O’Brien KD (2006) Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 26(8):1721–1728. https://doi.org/10.1161/01.ATV.0000227513.13697.ac

Zhao ZG, Liao YB, Peng Y et al (2013) Sex-related differences in outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis. Circ Cardiovasc Interv 6(5):543–551. https://doi.org/10.1161/circinterventions.113.000529

Thông tin
Thông tin xuất bản

Herz

Tập 46

1-8

Thông tin tác giả